Medtech Start-Ups: Quantib, Circadia Health, Tatch, BioSense, & more

Posted by Life Science Intelligence on Aug 11, 2020 10:40:42 AM
Find me on:

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Quantib is developing artificial intelligence application for medical imaging analyses

The company currently commercializes two FDA-approved radiology imaging analysis platforms – Quantib ND and Quantib Brain. In June 2020, the company received a grant from the European Innovation Council $2.4M. Strategic competitors in this space include GE Healthcare, Philips, and Siemens

Start a Free Trial to Medtech Start-Up Tracker Today

Contactless monitoring device company Circadia Health receives FDA Approval 

Circadia C100 is a contactless monitoring device powered by artificial intelligence. The device remotely monitors patients for respiratory complications. Competitors offering similar solutions for the monitoring respiratory failure include SenTec and Welch Allyn

Surgical Robotic System, Digital Therapy, & Cardiac Imaging Startups in Medtech

Tatch is developing a novel patch to provide sleep clinic-quality monitoring to patients at home

Using flexible electronics and machine learning, Tatch has developed a comfortable patch capable of accurately monitoring 8 different vital variables. To-date the company has raised $4.3M million. Major competitors in this market include consumer wearable devices, such as Fitbit, as well as other companies such as Withings, Biostrap, and EarlySense.

Wireless ECG BioSense raises $500,000 in a June 2020 Seed Round

BioSense is developing a wireless ECG that can detect electrical activity in human and animal bodies through multiple layers of clothing or materials. Key strategics in the wearable ECG market include AliveCor, SonoHealth, and Omron.

CryOSA is developing novel treatments for obstructive sleep apnea

It is estimated that approximately 18 to 22 million Americans have some form of sleep apnea. The company raised $8.3M during a Series A round led by HOYA and Sante Ventures in June 2020. Other competitors developing medtech solutions for obstructive sleep apnea include Inspire and SomnoMed.

A pediatric pulmonary valve for the treatment of pediatric congenital heart disease is in development at PolyVascular

The polymeric valves will be delivered via a transcatheter approach to treat congenital heart disease, a common birth defect in infants. The transcatheter heart valve market has rapidly grown in recent years, however, Abbott is the only competitor with a valve indicated for use in infants and children.

Sonavex is using ultrasound to monitor the flow of blood

Using a bioresorbable polymeric implant and ultrasound technology, physicians can visualize and quantify anastomotic blood clots post-surgery. To-date the company has raised $11.4M. The EchoMark implant and EchoSure system received clearance from the FDA in 2019. Cook Medical and Medistim offer similar solutions for the monitoring of blood flow.  

Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Start-Up Tracker.

Topics: Startup, Medtech, Medtech Venture Capital

Stay connected with our latest posts:

About the Author

Life Science Intelligence (LSI) helps medtech executives make better strategic decisions by delivering unique market data and business insights. For over 13 years LSI has been working with industry giants – Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal, Boston Scientific, and Becton Dickinson, among others. LSI products are also leveraged by the most successful start-ups, innovators, investors, and service companies that compete in medtech. LSI is the organizer of The Emerging Medtech Summit held annually in Southern California.

Contact LSI here, via phone 714 847 3540, or email info@lsintel.com